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Background: Cimetidine is a potent histamine H2-receptor antagonist widely used in 
treatment of peptic ulcer disease. The aim of this study was to evaluate the effect of chronic 
cimetidine treatment at therapeutic dose of 30 mg kg-1 on serum levels of testosterone, FSH, 
LH and estradiol and possible ameliorative effect of vitamin C on any derangements induced 
by cimetidine treatment. Methods: Forty adult male Wistar rats were divided into four groups 
(n = 10) and treated orally for 60 days. Group 1 (control) received distilled water; group 2 
received cimetidine (30 mg kg-1); group 3 received cimetidine (30 mg kg-1) + vitamin C (25 
mg kg-1) and group 4 received cimetidine (30 mg kg-1) + vitamin C (50 mg kg-1). At the end of 
the study each animal was anaesthetized by chloroform inhalation in a gas chamber and blood 
was collected by heart puncture. Serum testosterone, FSH, LH and estradiol levels were 
determined using ELISA kits. Results:  Serum levels of testosterone (5.11 ± 0.89), FSH (4.07 
± 0.16) and estradiol (3.13 ± 0.08) of the cimetidine-treated group were higher than that of the 
control (1.94 ± 0.53, 1.96 ± 0.04 and 1.52 ± 0.23, respectively) at P ≤ 0.05 while the value for 
LH of the two groups were not significantly different. Treatment with vitamin C reversed the 
cimetidine-induced increase in the levels of some of these hormones. Conclusion: It was 
concluded that chronic cimetidine administration at therapeutic dose increased serum levels of 
testosterone, FSH and estradiol, but not LH and vitamin C at the dose of 25 mg kg-1 co-






Cimetidine is a potent histamine H2-receptor antagonist 
(Hamid et al., 2010) that is widely prescribed 
worldwide (Al-Nailey, 2010), and is also available 
without prescription (Luangpirom and Komnont, 2011; 
Aprioku et al., 2014). Cimetidine is an important drug 
commonly used in the treatment of gastric and 
duodenal ulcers (Aprioku et al., 2014). Because it is a 
H2-receptor antagonist it has the ability to block the 
actions of histamine on H2-receptors (Winters et al., 
1979; Katzung, 1989; Ronald and Ashley, 2003) in the  
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parietal cells of the stomach, thereby preventing the 
production of acid (Rang et al., 2012; Altman, 1998). 
Thus, it promotes the healing of these ulcers and can 
also be used for prophylaxis of stress ulcers (Schupp et 
al., 2003). However, cimetidine has been reported to be 
a reproductive toxicant (Franca et al., 2000; Sasso-
Cerri et al., 2001; Sasso-Cerri and Cerri, 2008). 
Previous works on cimetidine were carried out using 
both acute and chronic high doses of the drug to 
demonstrate its effect on the reproductive system. 
However little is known about such effects of the drug 
at therapeutic doses (Aprioku et al., 2013), as the most 
common use of cimetidine is over long duration 
(Hamid et al., 2010) at therapeutic doses. Despite its 
known side effects at higher doses than the therapeutic 
dose, cimetidine is still widely used, hence the need for 
a remedy to the potentially serious side effects. This 
study sought to evaluate the effects of chronic 
cimetidine administration at therapeutic doses on 
testosterone, follicle stimulating hormone (FSH), 
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leutinising hormone (LH) and estradiol and the possible 
ameliorative effects of vitamin C. 
 
MATERIALS AND METHODS 
Animals and Conditions  
A total of forty adult male Wistar rats weighing 
between 110-130g, at 90 days old were obtained from 
the animal house of the Department of Human 
physiology, Bayero University, Kano, where the study 
was carried out. They were housed in plastic cages with 
plastic bottom and maintained under adequate 
ventilation in the animal house. They were also allowed 
access to standard laboratory rat chow and tap water ad 
libitum throughout the study. Experimental protocols 
were in accordance with the guidelines for animal 
research, as stated in the NIH Guidelines for the Care 
and Use of Laboratory Animals (National Academy of 
Sciences and National Institute of Health Publications, 
2011). 
Preparation of Administered Drugs 
Five tablets (1000mg) of cimetidine 200 mg (Gasrol, 
Sam Pharmaceuticals, Nigeria) were crushed into 
powder using pestle and mortar and dissolved in 
100mls of distilled water to make a stock solution 
containing cimetidine, at a concentration of 10 mg ml-1. 
This was stored at room temperature, protected from 
light and used up within 3 days. Similarly, a stock 
solution containing vitamin C at a concentration of 10 
mg ml-1 was prepared from pure grade vitamin C 
powder (Ascorbic Acid, Bulk supplements, Nevada, 
U.S.A) and stored at room temperature, protected from 
light and used within 3 days.   
Grouping and Treatments 
The animals were randomly divided into 4 groups of 10 
rats each. They were administered with either drugs or 
distilled water orally using metallic cannula at 10:00am 
daily for 60 days. Group 1 (Control) received distilled 
water; group 2 received cimetidine at a dose of 30 mg 
kg-1; group 3 received cimetidine (30 mg kg-1)+ vitamin 
C (25 mg kg-1); and group 4 received cimetidine 30 mg 
kg-1 + vitamin C (50 mg kg-1). The rats were weighed at 
the beginning of the experiment and every week 
subsequently. Doses of administered drugs were 
adjusted according to the body weights of the animals. 
Sacrifice of Animals and Samples Collection   
At the end of the experiment, the live weight of each rat 
was assessed before sacrifice. Subsequently each rat 
was anaesthetized by chloroform inhalation in a gas 
chamber. The chest was then opened and blood samples 
aspirated by heart puncture using 10ml syringe. Blood 
collected was quickly discharged into plain bottles for 
determination of hormonal levels. 
Hormonal Assays 
Whole blood collected in a plain bottle was allowed to 
clot by leaving it undisturbed at room temperature for a 
period of 15-30 minutes. The clot was then removed by 
centrifuging at 2000 revolutions per minute for 10 
minutes in a centrifuge (Jenalab Medical, England). 
The resulting supernatant known as serum was 
immediately transferred into a clean plain sample bottle 
using a Pasteur pipette and immediately stored in a 
freezer at –20°C and freeze-thaw cycles avoided 
(Henry, 1979; Thavasu et al., 1992; Adediran and 
Kolapo, 2014). This was subsequently used to 
determine the levels of testosterone, FSH, LH and 
estradiol. Assay for these hormones was carried out 
using commercially available enzyme-linked 
immunosorbent assay (ELISA) kits (Fortress 
diagnostics, Antrim, U.K.) according to manufacturer’s 
instructions.  
Statistical Analysis 
Data were presented as mean ± SEM and analyzed 
using Statistical Package for Social Sciences (SPSS) 
version 20.0 (SPSS Inc, Chicago, United States). One-
way ANOVA and Tukey post-hoc tests were used to 




Figure 1 shows serum concentration of testosterone 
(ng/ml) of rats following 60 days of administration. 
Serum testosterone concentration of group 2 rats (5.11 
± 0.89) was significantly higher compared to group 1 
(1.94 ± 0.53) (P = 0.011). This shows that 
administration of 30 mg kg-1 cimetidine increased 
serum testosterone concentration in the treated rats. 
There was no significant difference in serum 
testosterone concentration between group 3 rats (4.39 ± 
0.51) and group 1 (1.94 ± 0.53) (P = 0.070), indicating 
that 25 mg kg-1 vitamin C reversed (reduced) the 
increase in testosterone concentration caused by 
cimetidine administration. Serum testosterone levels of 
group 4 rats (4.54 ± 0.71) was significantly higher 
compared to group 1 (1.94 ± 0.53) (P = 0.049) 
indicating that 50 mg kg-1 vitamin C did not reverse 
(reduce) the effect of cimetidine. There was however 
no significant difference in serum testosterone 
concentration between group 4 (4.54 ± 0.71) and group 
3 rats (4.39 ± 0.51) (P = 0.999). 
 
Follicle stimulating hormone (mIU/ml) 
Figure 2 shows serum concentration of FSH following 
60 days of administration. The serum concentration of 
FSH in group 2 rats (4.07 ± 0.16) was significantly 
higher compared to group 1 (1.96 ± 0.04) (P = 0.001). 
This shows that administration of 30 mg kg-1 cimetidine  
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Fig. 1: Serum concentration of testosterone following 60 days of administration (Mean ± S.E.M., n = 10). a = Significant (P ≤ 




Fig. 2: Serum concentration of FSH following 60 days of administration (Mean ± S.E.M., n = 10). a = Significant (P ≤ 0.05) 
compared to group 1 (control group). b = Not significant (P > 0.05) compared to group 1 (control group) 
 
 increased serum FSH concentration in the rats. There 
was no significant difference in serum FSH    
concentration  of   group 3   (1.90 ± 0.01) and group 4 
rats (1.90 ± 0.01) compared to group 1 (1.96 ± 0.04) (P 
= 0.962 and P = 0.947, respectively) suggesting that 
vitamin C at both doses reversed the raised FSH 
concentration caused by 30 mg kg-1 cimetidine back to 
normal. There was no significant difference in serum 
FSH concentration of group 4 (1.90 ± 0.01) and group 
3 rats (1.90 ± 0.01) (P = 1.000). 
 
Leutinising hormone (mIU/ml) 
Serum LH concentration of group 2 (2.77 ± 1.05), 
group 3 (0.49 ± 0.39) and group 4 rats (0.05 ± 0.05) 
were not significantly different compared to group 1 
(1.38 ± 0.60) (P = 0.423, P = 0.753 and P = 0.457, 
respectively) as shown in figure 3. This shows that 30 
mg kg-1 cimetidine, or its co- administration with 25 mg 
kg-1 vitamin C and 50 mg kg-1 vitamin C did not 
significantly affect LH concentration. There was also 
no significant difference in serum LH concentration of 
group 4 (0.05 ± 0.05) and group 3 rats (0.49 ± 0.39) (P 
= 0.961). Though the differences between the groups in 
LH values were not significant, a similar trend was 
observed in which cimetidine 30 mg kg-1 increased the 
hormonal level compared to control, while 
administration of both doses of vitamin C decreased the 
levels towards the normal. 
 
Estradiol (pg/ml) 
Figure 4 shows serum estradiol concentration following 
60 days of administration. Serum estradiol 
concentration of group 2 (3.13 ± 0.08), group 3 (2.72 ± 
0.04) and group 4 rats (2.70 ± 0.04) were significantly 
higher compared to group 1 (1.52 ± 0.23) (P = 0.001, P 
= 0.001 and P = 0.001, respectively), indicating that 
serum estradiol levels were significantly increased in 
these groups due to cimetidine administration alone as 
well as in combination with vitamin C. This also 
suggests that vitamin C at both doses did not reverse 
the cimetidine-induced increase in estradiol back to 
normal. There was also no significant difference in 
serum estradiol levels of group 4 (2.70 ± 0.04) and 
group 3 rats (2.72 ± 0.04) (P = 0.999).  
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Fig. 3: Serum concentration of LH following 60 days of administration (Mean ± S.E.M., n = 10). b = Not significant (P > 0.05) 




Fig.4: Serum concentration of estradiol following 60 days of administration (Mean ± S.E.M., n = 10). a = Significant (P ≤ 0.05) 




Cimetidine has caused a significant increase in serum 
testosterone. The mechanism of this effect may be 
related to the anti-androgenic properties of cimetidine 
which acts as a non-steroidal anti-androgen by 
inhibiting testosterone transformation to 
dihydrotestosterone (Baba et al., 1981) as well as 
inhibiting dihydrotestosterone from binding to the 
androgen receptor (Winters et al., 1979; Funder and 
Mercer, 1979) thereby preventing its action. This in 
turn may result in accumulation of testosterone due to 
its decreased conversion to dihydrotestesterone. The 
decrease activity of dihydrotestosterone because of its 
inability to bind on the androgen receptors may result 
in increased release of gonadotrophin in order to 
facilitate the release of more testosterone to bind to the 
androgen receptors to maintain spermatogenesis. Also, 
the toxic effect of cimetidine on testicular structures 
with subsequent affectation of its function as reported 
by Sawyer et al. (1981) as well as Kaman and 
Kazerouni (2002) may result in a feedback mechanism  
 
 
that will increase testosterone level in an effort to 
enable the testis function properly. In addition, 
cimetidine which is similar to other anti–androgens 
such as flutamide and cyproterone (Walsh et al., 1972; 
Neuman et al., 1977) have been shown to cause an 
increase in gonadotrophin levels by antagonizing the 
negative feedback control of gonadotrophin secretion 
by androgens, thus resulting in increased testosterone 
concentration (Wang et al., 1982; Knigge et al., 1983).  
The findings of this study is in agreement with that of 
Van Thiel et al. (1979), Penden et al. (1981) as well as 
Wang et al. (1982) who reported increased testosterone 
level. The findings however, disagree with those of 
Baba et al. (1981) and Parker et al. (1984), who 
reported a decrease in testosterone levels; and others 
(Leslie et al., 1981; McGivern 1987; Pinelli et al., 
1987; Franca et al., 2000; Hammodi et al., 2011; 
Luangpirom and Komnont, 2011) who reported no 
change in serum testosterone level.  
Treatment with vitamin C at 25 mg kg-1 reversed the 
effect of cimetidine. This may be related to the 
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antioxidant effect of vitamin C (Sharma and 
Bhattacharya, 2010), and may indicate oxidative stress 
as the possible mechanism of the cimetidine-induced 
increase in serum testosterone level. To support this, 
treatment with vitamin C at 50 mg kg-1 did not reverse 
the effect of cimetidine. This may be related to the pro-
oxidant effect of vitamin C on testes as reported 
previously (Yarube et al., 2014). 
The increase in serum levels of FSH caused by 
cimetidine may be a compensatory response to 
impaired spermatogenesis (Rosen and Weintraub, 
1971; Leonard et al., 1972; Franchimont et al., 1972; 
Van Thiel, et al., 1972 and De Kretser et al., 1974) 
resulting from toxic effect of cimetidine on testicular 
structures (Franca et al., 2000), inadequate testosterone 
available for spermatogenesis due to its inability to 
bind to receptors (Sivelle et al., 1982), and the 
antagonizing effect of cimetidine on the negative 
feedback control of gonadotrophin secretion by 
androgens (Wang et al., 1982). The findings of this 
study is in agreement with that of Bélisle et al. (1982), 
Spona et al. (1987), Franca et al. (2000) and Hammodi 
et al. (2011). These findings however, disagreed with 
those of Barber and Hoare (1979), Nelis and Van de 
Meene (1980), Valk, England and Marshall (1981) and 
Hayakawa et al. (1982) who reported that there was no 
change in serum FSH level, while Van Thiel et al. 
(1979) reported inadequate FSH response. Treatment 
with 25 mg kg-1 and 50 mg kg-1 of vitamin C restored 
serum FSH level showing that vitamin C has protected 
the testicular structures from the toxic effect of 
cimetidine, resulting in normalization of FSH levels. 
Though increase in FSH level due to cimetidine 
treatment was observed, it was without significant 
increase in LH. This may be due to the pulsatile nature 
of LH secretion, thus a single LH blood measurement 
may not adequately reflect the exact LH level (Wang et 
al., 1982). The findings of this study is in agreement 
with that of Barber and Hoare (1979), Nelis and Van de 
Meene (1980), Bélisle et al.  (1982), Hayakawa et al. 
(1982), Spona et al. (1987). The findings however, 
disagreed with those of Mahmud and Akhter (1995) 
who reported a significant increase in LH level, while 
Valk et al. (1981) reported a decrease in LH level after 
cimetidine treatment was discontinued. Treatment with 
25 mg kg-1 and 50 mg kg-1 of vitamin C had a reversal 
effect on the insignificant increase caused by 
cimetidine. Again, this effect may be due to the 
antioxidant properties of vitamin C (Angulo et al., 
2011).  
The increase in serum estradiol levels caused by 
cimetidine may be the result of inhibition of the 
degradation of estradiol following the inhibition of 
estradiol 2-hydroxylation by cimetidine in the liver 
(Galbraith and Jellinck, 1989) leading to increased 
serum estradiol level. An additional mechanism may be 
due to increased conversion of testosterone to estrogen 
(Hall, 2011) in the presence of high level of 
testosterone caused by treatment with cimetidine in this 
study. The findings of this study is in agreement with 
that of Valk et al. (1981), Galbraith and Jellinck (1989) 
and Michnovicz and Galbraith (1991) who reported an 
increase in estradiol levels. These findings however, 
disagreed with those of Barber and Hoare (1979), 
Bélisle et al. (1982) and Hayakawa et al. (1982) who 
reported no change in serum estradiol level. Treatment 
with vitamin C at 25 mg kg-1 and 50 mg kg-1 did not 
reverse the increase in serum estradiol level. Vitamin 
C, apparently did not interfere in the inhibition of 
estradiol 2-hydroxylation by cimetidine in the liver –the 
suggested mechanism of increased serum estradiol as 
described by Galbraith and Jellinck (1989).     
CONCLUSION 
Chronic administration of cimetidine at therapeutic 
dose caused a significant increase in serum levels of 
testosterone, FSH and estradiol, but not LH.  Vitamin C 
at the dose of 25 mg kg-1 co-administered with 
cimetidine ameliorated the serum increase in 
testosterone and FSH while vitamin C at the dose of 50 
mg kg-1 only ameliorated the serum increase in FSH. 
Study highlights potential serious side effects on 
male sex hormones associated with chronic 
cimetidine therapy and the beneficial effect of 
cimetidine co-treatment therapy with Vitamin C. 
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